Furthermore, postmortem brain studies have shown compounded risk for developing AD among hyperinsulinemic diabetics who also carry at least one ApoE-ε4 allele, and relative resistance to AD among non-diabetic, ApoE4-ε4 negative individuals. This evidence concerns the gene APOE and Alzheimer disease.